A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua

O. Sjaastad, F. Antonaci

Research output: Contribution to journalArticle

Abstract

Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continua. Piroxicam beta- cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicrania and six patients with hemicrania continua with a previously proven response to indomethacin. The study was conducted over a period of 3 weeks and in an open fashion. A placebo effect is considered to be negligible in these disorders. In such a comparison, piroxicam beta-cyclodextrin seemed inferior to indomethacin, in particular in chronic paroxysmal hemicrania.

Original languageEnglish
Pages (from-to)549-550
Number of pages2
JournalHeadache
Volume35
Issue number9
DOIs
Publication statusPublished - 1995

Fingerprint

Paroxysmal Hemicrania
Piroxicam
Indomethacin
Headache
Placebo Effect
piroxicam-beta-cyclodextrin

Keywords

  • chronic paroxysmal hemicrania
  • hemicrania continua
  • piroxicam

ASJC Scopus subject areas

  • Clinical Neurology
  • Neuroscience(all)

Cite this

A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua. / Sjaastad, O.; Antonaci, F.

In: Headache, Vol. 35, No. 9, 1995, p. 549-550.

Research output: Contribution to journalArticle

@article{db5b3fed2dcd49ff9e27415789cd1e25,
title = "A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua",
abstract = "Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continua. Piroxicam beta- cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicrania and six patients with hemicrania continua with a previously proven response to indomethacin. The study was conducted over a period of 3 weeks and in an open fashion. A placebo effect is considered to be negligible in these disorders. In such a comparison, piroxicam beta-cyclodextrin seemed inferior to indomethacin, in particular in chronic paroxysmal hemicrania.",
keywords = "chronic paroxysmal hemicrania, hemicrania continua, piroxicam",
author = "O. Sjaastad and F. Antonaci",
year = "1995",
doi = "10.1111/j.1526-4610.1995.hed3509549.x",
language = "English",
volume = "35",
pages = "549--550",
journal = "Headache",
issn = "0017-8748",
publisher = "wiley",
number = "9",

}

TY - JOUR

T1 - A piroxicam derivative partly effective in chronic paroxysmal hemicrania and hemicrania continua

AU - Sjaastad, O.

AU - Antonaci, F.

PY - 1995

Y1 - 1995

N2 - Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continua. Piroxicam beta- cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicrania and six patients with hemicrania continua with a previously proven response to indomethacin. The study was conducted over a period of 3 weeks and in an open fashion. A placebo effect is considered to be negligible in these disorders. In such a comparison, piroxicam beta-cyclodextrin seemed inferior to indomethacin, in particular in chronic paroxysmal hemicrania.

AB - Piroxicam beta-cyclodextrin has recently been observed to be equal to, or even possibly to be superior to, indomethacin (mainly with regard to side effects) in a single case of hemicrania continua. Piroxicam beta- cyclodextrin, 20 to 40 mg per day, was, accordingly, tried in six patients with chronic paroxysmal hemicrania and six patients with hemicrania continua with a previously proven response to indomethacin. The study was conducted over a period of 3 weeks and in an open fashion. A placebo effect is considered to be negligible in these disorders. In such a comparison, piroxicam beta-cyclodextrin seemed inferior to indomethacin, in particular in chronic paroxysmal hemicrania.

KW - chronic paroxysmal hemicrania

KW - hemicrania continua

KW - piroxicam

UR - http://www.scopus.com/inward/record.url?scp=0028839854&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0028839854&partnerID=8YFLogxK

U2 - 10.1111/j.1526-4610.1995.hed3509549.x

DO - 10.1111/j.1526-4610.1995.hed3509549.x

M3 - Article

C2 - 8530280

AN - SCOPUS:0028839854

VL - 35

SP - 549

EP - 550

JO - Headache

JF - Headache

SN - 0017-8748

IS - 9

ER -